Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

Anti-PrP antibodies inhibits SCN2A. 1 / 1

| 1

➶

reach

"Previous reports have shown that binding of anti-PrP antibodies to helix 1 region of PrP C, which is believed to play a crucial role in the conversion process XREF_BIBR, XREF_BIBR inhibits PrP Sc accumulation in ScN2a cells by preventing interaction of PrP C with PrP Sc XREF_BIBR, XREF_BIBR."

20339552

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...